Aspiro Therapeutics to Participate in RESI San Diego 2026
Tucson, Arizona | June 2, 2026 – Aspiro Therapeutics will participate in RESI San Diego 2026, one of the leading partnering conferences for early-stage life science companies, bringing together biotechnology innovators, investors, strategic partners, and industry leaders to accelerate the development of innovative healthcare technologies. During the conference, Chief Executive Officer and Co-Founder James Lovgren […]